An appraisal of hyoscine as an EEG activating agent.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000987:Antisocial Personality Disorder; D002540:Cerebral Cortex / Q000187:drug effects*; D002561:Cerebrovascular Disorders; D004569:Electroencephalography; D004827:Epilepsy; D004833:Epilepsy, Temporal Lobe; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders; D012559:Schizophrenia; D012601:Scopolamine / Q000009:adverse effects; D014785:Vision, Ocular / Q000187:drug effects
D012601:Scopolamine